Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Jefferies Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20

Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%

TIPRANKS
·
Aug 20

JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)

TIPRANKS
·
Aug 20

US Equity Indexes Rise as Treasury Yields Ease on Buyback Ramp

MT Newswires Live
·
Aug 20

Moderna $30 Bln Gain Implies Many Cancer Successes

Reuters
·
Aug 20

Midday Market Movers: Moderna, Pilgrims Pride, Target, Gold Miners & More

Deep News
·
Aug 20

Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer

TIPRANKS
·
Aug 20

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 20

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

U.S. Stocks on the MOVE-Marvell, Pilgrim's Pride, ServiceNow

Reuters
·
Aug 19

Top Midday Stories: Treasury Lifts Buyback Cap on Long-Dated Securities; Moderna, Merck Say Melanoma Vaccine Meets Primary Endpoint in Trial

MT Newswires Live
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

Moderna Moves Back Toward Covid-Era Valuation with Latest mRNA Update

Dow Jones
·
Aug 19

Moderna : RBC Raises Target Price to $130 from $45

THOMSON REUTERS
·
Aug 19

Leerink says cancer vaccine win should sustain Merck momentum into fall

TIPRANKS
·
Aug 19

Moderna Short Sellers Face About $4.8 Bln on Paper Losses on Wednesday After Stock Surges to $159, According to Ortex Estimates

THOMSON REUTERS
·
Aug 19